Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

25.94
+0.19000.74%
Post-market: 25.93-0.0100-0.04%19:59 EST
Volume:37.06M
Turnover:959.80M
Market Cap:147.01B
PE:18.37
High:26.18
Open:25.70
Low:25.66
Close:25.75
Loading ...

Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents

Reuters
·
8 hours ago

Why Moderna (MRNA) Stock Is Rallying Today

Insider Monkey
·
9 hours ago

Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute

GuruFocus.com
·
9 hours ago

Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court

MT Newswires Live
·
11 hours ago

German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports

Dow Jones
·
11 hours ago

Trimtech Therapeutics - Additional Investors Also Include Eli Lilly , MP Healthcare Venture Management, Cambridge Enterprise Ventures, Start Codon

THOMSON REUTERS
·
Yesterday

Trimtech Therapeutics-Financing Led by Cambridge Innovation Capital, Dementia Discovery Fund With M Ventures, Pfizer Ventures Joining

THOMSON REUTERS
·
Yesterday

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent

Reuters
·
Yesterday

German Court Rules in Favour of Moderna in Patent Lawsuit Against BioNTech and Pfizer

THOMSON REUTERS
·
Yesterday

Court Rules Pfizer, BioNTech Must Pay "Appropriate" Damages and Compensation; Ruling Can Be Appealed

THOMSON REUTERS
·
Yesterday

3 Ultra-Cheap Dividend Stocks to Buy Right Now

Motley Fool
·
Yesterday

Pfizer could use existing U.S. production to counter tariff hit, Reuters reports

TIPRANKS
·
04 Mar

1 Stock Down 43% That Looks Too Cheap to Ignore

Motley Fool
·
04 Mar

Q4 2024 Mersana Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
04 Mar

Pfizer could use existing US manufacturing to counter potential tariff hit

Reuters
·
04 Mar

Pfizer could move outside manufacturing to the US, says CEO

Reuters
·
03 Mar